Birmingham, Alabama – July 10, 2024 — The ProxsysRx specialty pharmacy team, led by Vice President Heather Brooks and Compliance & Accreditation Manager Lauren Robinson,
(Pictured Above: ProxsysRx VP and 340B team leader Heather Brooks) It’s no secret that manufacturer drug restrictions have devastated the 340B programs of countless covered
(NOTE: On April 10, ProxsysRx released an announcement of its recently-signed contract to build and manage a specialty pharmacy for Massachusetts’ Holyoke Medical Center.) SEGMENT
(NOTE: On April 10, ProxsysRx released an announcement of its recently-signed contract to build and manage a specialty pharmacy for Massachusetts’ Holyoke Medical Center.) In
(NOTE: On April 10th, ProxsysRx released an announcement of its recently-signed contract to build and manage a specialty pharmacy for Massachusetts’ Holyoke Medical Center.) In
(NOTE: Last week, ProxsysRx released an announcement of its recently-signed contract to build and manage a specialty pharmacy for Massachusetts’ Holyoke Medical Center.) The ultimate Win-Win situation in
BIRMINGHAM, AL April 10, 2024 — Massachusetts’ Holyoke Medical Center (HMC), a 219- bed independent community hospital with more than 1600 employees, has contracted with
BIRMINGHAM, AL — March 28, 2024 — ProxsysRx has signed an agreement to build and own a pharmacy at St. James Parish Hospital, a critical
Congress established the 340B program to help non-profit hospitals fill-in the revenue gaps inherent to their business models. What very few eligible health systems realize,
Below are selected excerpts from an in-depth roundtable discussion outlining how eligible health systems can ensure the success of their onsite specialty pharmacies. To watch
